Deakin University
Browse

File(s) not publicly available

AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas

conference contribution
posted on 2017-09-01, 00:00 authored by Mustafa Khasraw, MICHAEL HOFMANMICHAEL HOFMAN, L Chantrill, N Pavlakis, V Gebski, A J Gill, B Markman, S Yip, E Gibbs, C Karapetis, S F Wong, D T Ransom, M Michael, K Wilson, J Simes, L Lipton
AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas

History

Event

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Volume

28

Publisher

OXFORD UNIV PRESS

Location

Madrid, SPAIN

Start date

2017-09-08

End date

2017-09-12

ISSN

0923-7534

eISSN

1569-8041

Language

English

Publication classification

E3 Extract of paper

Title of proceedings

ANNALS OF ONCOLOGY

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC